CSS
CME icon

Cubist Systematic Strategies’s CME Group CME Stock Holding History

Cubist Systematic Strategies’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$20.3M Sell
75,000
-36,817
-33% -$10M 0.1% 276
2025
Q2 		$30.8M Buy
111,817
+36,817
+49% +$10M 0.14% 164
2025
Q1 		$19.9M Hold
75,000
– – 0.12% 196
2024
Q4 		$17.4M Sell
75,000
-138,297
-65% -$31.8M 0.11% 251
2024
Q3 		$47.1M Sell
213,297
-92,766
-30% -$19.2M 0.29% 39
2024
Q2 		$60.2M Buy
306,063
+203,769
+199% +$42.1M 0.41% 20
2024
Q1 		$22M Buy
102,294
+25,671
+34% +$5.39M 0.13% 165
2023
Q4 		$16.1M Buy
76,623
+43,299
+130% +$9.24M 0.11% 227
2023
Q3 		$6.67M Buy
33,324
+18,158
+120% +$3.61M 0.05% 589
2023
Q2 		$2.81M Sell
15,166
-36,691
-71% -$6.78M 0.02% 1233
2023
Q1 		$9.93M Sell
51,857
-278,928
-84% -$50.4M 0.06% 460
2022
Q4 		$55.6M Buy
330,785
+33,085
+11% +$5.75M 0.32% 4
2022
Q3 		$52.7M Buy
297,700
+226,419
+318% +$44.7M 0.3% 5
2022
Q2 		$14.6M Sell
71,281
-83,376
-54% -$17.7M 0.09% 240
2022
Q1 		$36.8M Buy
154,657
+120,837
+357% +$28.4M 0.31% 10
2021
Q4 		$7.73M Buy
33,820
+4,165
+14% +$916K 0.07% 376
2021
Q3 		$5.74M Sell
29,655
-20,803
-41% -$4.21M 0.07% 397
2021
Q2 		$10.7M Buy
50,458
+23,324
+86% +$4.92M 0.12% 183
2021
Q1 		$5.54M Buy
27,134
+11,495
+74% +$2.26M 0.07% 398
2020
Q4 		$2.85M Sell
15,639
-58,046
-79% -$9.87M 0.04% 746
2020
Q3 		$12.3M Sell
73,685
-22,210
-23% -$3.74M 0.18% 90
2020
Q2 		$15.6M Buy
95,895
+57,849
+152% +$10.4M 0.27% 46
2020
Q1 		$6.58M Buy
38,046
+23,987
+171% +$4.77M 0.18% 120
2019
Q4 		$2.82M Buy
14,059
+11,028
+364% +$2.26M 0.05% 568
2019
Q3 		$641K Sell
3,031
-7,458
-71% -$1.56M 0.01% 1175
2019
Q2 		$2.04M Sell
10,489
-55,688
-84% -$10.3M 0.04% 678
2019
Q1 		$10.9M Buy
+66,177
New +$11.7M 0.35% 27
2018
Q4 		– Sell
-10,788
Closed -$1.84M – 2087
2018
Q3 		$1.84M Buy
10,788
+3,276
+44% +$552K 0.1% 238
2018
Q2 		$1.23M Buy
7,512
+3,527
+89% +$576K 0.06% 403
2018
Q1 		$645K Buy
3,985
+1,571
+65% +$250K 0.04% 661
2017
Q4 		$353K Sell
2,414
-751
-24% -$107K 0.02% 1134
2017
Q3 		$429K Buy
3,165
+2,467
+353% +$312K 0.02% 916
2017
Q2 		$87K Sell
698
-5,287
-88% -$632K 0.01% 1469
2017
Q1 		$711K Buy
5,985
+2,589
+76% +$311K 0.05% 481
2016
Q4 		$392K Sell
3,396
-18,361
-84% -$2.04M 0.03% 804
2016
Q3 		$2.27M Sell
21,757
-4,711
-18% -$492K 0.15% 162
2016
Q2 		$2.58M Buy
26,468
+18,668
+239% +$1.76M 0.15% 138
2016
Q1 		$749K Sell
7,800
-21,231
-73% -$1.93M 0.04% 577
2015
Q4 		$2.63M Buy
29,031
+23,727
+447% +$2.23M 0.15% 155
2015
Q3 		$492K Buy
5,304
+3,720
+235% +$354K 0.02% 965
2015
Q2 		$147K Sell
1,584
-16,682
-91% -$1.56M 0.01% 1549
2015
Q1 		$1.73M Buy
18,266
+7,993
+78% +$740K 0.08% 334
2014
Q4 		$911K Buy
10,273
+6,036
+142% +$512K 0.05% 552
2014
Q3 		$339K Sell
4,237
-12,298
-74% -$927K 0.02% 1038
2014
Q2 		$1.17M Buy
+16,535
New +$1.16M 0.07% 420

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cubist Systematic Strategies's CME Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its CME Group (CME) stake by 33% in Q3 2025, selling an estimated $10M and leaving 75,000 shares worth $20.3M. The position accounts for 0.1% of the portfolio, ranked #276.

Cubist Systematic Strategies first reported a position in CME in Q2 2014 and has held it in 45 quarters since. The position peaked at $60.2M in Q2 2024. 1,650 funds tracked by Wall St. Rank hold CME as of Q3 2025.

  • Cubist Systematic Strategies held 75,000 shares of CME Group worth $20.3M as of Q3 2025.
  • Cubist Systematic Strategies sold 36,817 CME Group shares in Q3 2025, an estimated $10M.
  • CME Group made up 0.1% of Cubist Systematic Strategies's portfolio in Q3 2025, its #276 holding.
  • Cubist Systematic Strategies first reported a position in CME Group in Q2 2014 and has held it in 45 quarters since.
  • Cubist Systematic Strategies's CME Group position peaked at $60.2M in Q2 2024.
  • 1,650 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.